Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.71% | 2.58% | 38.90% | 7.72% | 9.28% |
| Total Depreciation and Amortization | 1.76% | -3.91% | -3.22% | 6.09% | 31.66% |
| Total Amortization of Deferred Charges | -61.54% | -100.00% | -100.00% | -100.00% | 129.41% |
| Total Other Non-Cash Items | -56.37% | -43.38% | -71.67% | 17.25% | 21.22% |
| Change in Net Operating Assets | 43.10% | 84.80% | -134.12% | -1,132.26% | -1,667.89% |
| Cash from Operations | -11.15% | -2.62% | -3.62% | 5.93% | 5.17% |
| Capital Expenditure | -524.27% | -29.41% | 55.74% | 79.96% | 87.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,097.07% | -86,885.29% | 55.74% | 79.96% | 87.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 61,248.41% | -- | -9.73% | 3,703,466.67% |
| Repurchase of Common Stock | 26.24% | -- | -162,916.95% | -- | -1,310.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.09% | 126,632.89% | -162,916.95% | -9.73% | 1,585,328.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -132.27% | -95.72% | -434.10% | 10.16% | 437.78% |